Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06651632 · ClinicalTrials.gov registry record · NA
WATER IV Prostate Cancer
A NA study of Localized Prostate Cancer, sponsored by PROCEPT BioRobotics.
- Recruiting
- Registry status
- NA
- Development phase
- 280
- Enrollment target
- 20
- Study locations
NCT06651632: Recruiting NA study of Localized Prostate Cancer, sponsored by PROCEPT BioRobotics.
NCT06651632 is a NA study of Localized Prostate Cancer that is actively recruiting participants, run by PROCEPT BioRobotics. The registered enrollment target is 280 participants, above the 71-participant average among 6 other Localized Prostate Cancer trials with a reported enrollment target (294% higher). The trial reports 20 study locations across 13 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06651632, a NA study of Localized Prostate Cancer, is actively recruiting participants, sponsored by PROCEPT BioRobotics.
- RECRUITING
- Registry status
- NA
- Development phase
- 280 participants
- Enrollment target
- 20
- Study locations
Study Summary
This is a multicenter, prospective, randomized clinical trial that aims to assess the safety and efficacy of Aquablation Therapy in men with low-risk to intermediate to high-risk localized prostate cancer who are candidates for, or have opted for, prostatectomy. Participants will be randomized to either Aquablation Therapy or radical prostatectomy and followed up to 10 years.
Conditions Studied
Interventions
- PROCEDURE Radical Prostatectomy
- DEVICE Aquablation Therapy
Study Locations (20)
Florida
- Advanced Research - Delray Beach
- University of Miami - Miami
- Florida Urology Partners - Tampa
- Trophy Point Urology - Tampa
Arizona
- Arizona State Urological Institute - Chandler
- East Valley Urology Center - Mesa
Illinois
- University of Chicago - Chicago
- Endeavor Health - Glenview
Nebraska
- Kearney Urology Center - Kearney
- Adult & Pediatric Urology - Omaha
New York
- Integrated Medical Professionals, PLLC - New York
- University of Rochester Medical Center - Rochester
California
- University of Southern California - Los Angeles
Colorado
- Boulder Medical Center - Boulder
Georgia
- Georgia Urology - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 280 participants |
| Start Date | 2025-02-03 |
| Est. Completion | 2037-01 |
| Phase | NA |
What NCT06651632 shows while recruiting
NCT06651632 is an interventional study that assigns participants to a tested intervention. The registered 280 participants enrollment target is mid-sized for trials with a published cap, above the 71-participant average among 6 other Localized Prostate Cancer trials with a reported enrollment target (294% higher).
The record links to 1 condition, with Localized Prostate Cancer appearing as the primary indexed condition, and to 2 interventions - of which Radical Prostatectomy is the first listed.
NCT06651632 names 20 study sites across 13 states, led by Florida, Arizona, Illinois.
Frequently Asked Questions
What is clinical trial NCT06651632 about?
NCT06651632 is a clinical study titled "WATER IV Prostate Cancer". This is a multicenter, prospective, randomized clinical trial that aims to assess the safety and efficacy of Aquablation Therapy in men with low-risk to intermediate to high-risk localized prostate cancer who are candidates for, or have opted for, prostatectomy. Participants will be randomized to ei...
What is the current status of trial NCT06651632?
This trial is currently recruiting. It is a NA study. The enrollment target is 280 participants. The study started on 2025-02-03. Estimated completion is 2037-01.
What conditions does trial NCT06651632 study?
This clinical trial studies the following conditions: Localized Prostate Cancer.
What interventions are being tested in trial NCT06651632?
The interventions under investigation include: Radical Prostatectomy (PROCEDURE), Aquablation Therapy (DEVICE).
Who is sponsoring clinical trial NCT06651632?
This trial is sponsored by PROCEPT BioRobotics, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06651632 being conducted?
This trial has 20 study locations across Arizona, California, Colorado, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Localized Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
PRCT002 PRostate Cancer Treatment With the AQUABEAM Robotic System
ACTIVE NOT RECRUITING · NA
-
PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs
ACTIVE NOT RECRUITING · NA
-
18F-DCFPyL Imaging as a Method to Assess Treatment Response to Stereotactic Body Radiation Therapy
RECRUITING · Phase 2
-
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
RECRUITING · Phase 2
-
Study of the Efficacy, Safety and Quality of Life After TOOKAD® Soluble (VTP) for Intermediate Risk Prostate Cancer.
ACTIVE NOT RECRUITING · Phase 2
-
Use of Recombinant Adenovirus Therapy to Treat Localized Prostate Cancer
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04084730 · 280 participants · Phase 2
Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer
- NCT04518657 · 280 participants · NA
Internet-Delivered Lifestyle Physical Activity Intervention for Cognitive Processing Speed in Multiple Sclerosis
- NCT04634916 · 280 participants · NA
Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System
- NCT04829617 · 280 participants · NA
Promoting Well-being and Health in Heart Failure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI